Corbus Pharmaceuticals Holdings Inc. Stock Falls 7.0%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. slid 7.0% to $9.46 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.3% to 26,605.36 and Dow Jones Industrial Average falling 0.1% to 53,975.98.

The stock's fall snapped a four-day winning streak.

Corbus Pharmaceuticals Holdings Inc. closed 54.0% short of its 52-week high of $20.56, which the company achieved on October 20th.

The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 0.4% to $5.02, Fortress Biotech Inc. rose 3.0% to $2.75, and Viking Therapeutics Inc. rose 0.53% to $34.44.

Trading volume totaled 335,566, compared to the 50-day average of 412,692.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 10, 2026 16:32 ET (20:32 GMT)